Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) Stock Short Interest Report for October

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totaling 56,196 shares, a growth of 76.8% from the September 30th total of 31,793 shares. Based on an average trading volume of 15,975 shares, the days-to-cover ratio is currently 3.5 days.

Medexus Pharmaceuticals Price Performance

Shares of MEDXF remained flat at $3.56 during trading hours on Monday. The company had a trading volume of 1,030 shares, compared to its average volume of 13,084. Medexus Pharmaceuticals has a fifty-two week low of $1.80 and a fifty-two week high of $3.96. The company’s fifty day moving average price is $3.56 and its two-hundred day moving average price is $2.98.

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company focused on acquiring, commercializing and supporting differentiated prescription products in North America. The company serves healthcare providers and patients primarily in the United States and Canada, with an emphasis on products addressing specialty and underserved therapeutic markets.

Medexus’ portfolio has included IXINITY, a recombinant factor IX replacement therapy used to prevent and control bleeding in people with hemophilia B; Rasuvo, a single-dose subcutaneous methotrexate injection used for certain rheumatoid arthritis and juvenile idiopathic arthritis patients; and Gleolan, an oral diagnostic imaging agent used during surgery to help visualize malignant glioma tissue.

The company’s business model is centered on licensing, acquiring and commercializing pharmaceutical products rather than conducting broad-based drug discovery.